Eden Research (LON:EDEN) Trading Down 3.3% – Here’s Why

Posted by Andrew Walz on Feb 21st, 2025

Eden Research plc (LON:EDEN – Get Free Report) was down 3.3% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares were traded during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The business has a 50-day simple moving average of GBX 3.88 and a two-hundred day simple moving average of GBX 3.95. The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insiders Place Their Bets

In related news, insider Lykele van der Broek purchased 256,000 shares of the business’s stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.